ESC 365 - Acute treatment of levosimendan attenuates chronic doxorubicin-induced cardiomyopathy in vivo: implication of the critical role of inotropic action

ESC Premium Access

Acute treatment of levosimendan attenuates chronic doxorubicin-induced cardiomyopathy in vivo: implication of the critical role of inotropic action

Session: Best Posters 5 - Best Posters in comorbidities in heart failure

Topic: Cardiotoxicity of drugs

Speaker: Doctor P. Efentakis (Athens, GR)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Panagiotis Efentakis

National & Kapodistrian University of Athens, Athens (Greece)

0 follower

4 more presentations in this session

Best Posters in comorbodities in heart failure

Empagliflozin reduces the doxorubicine-induced myocardial dysfunction.

Speaker: Doctor J. Sabatino (Padova, IT)

Cardiorenohepatic syndrome reflects severity of decompensated heart failure and is related with worse prognosis

Speaker: Associate Professor A. Soloveva (Saint Petersburg, RU)

Iron deficiency predicted hospitalizations in elderly patients with symptoms of heart failure

Speaker: Mrs M. Olofsson (Skelleftea, SE)

Access the full session

Best Posters 5 - Best Posters in comorbidities in heart failure

Speakers: Doctor P. Efentakis, Doctor J. Sabatino, Associate Professor A. Soloveva, Mrs M. Olofsson

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources